Evidence map›Paper›PMID 36743693›Full record

ArticleOxidative medicine and cellular longevity2023

Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing.

Mingjun Zheng, Yuexin Hu, Ouxuan Liu, Siting Li, Yuxuan Wang, Xinru Li, Juanjuan Liu, Qing Yang, Xiao Li, Bei Lin

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Mingjun Zheng *Department of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, China.
Yuexin Hu *Department of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, China.
Ouxuan LiuDepartment of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, China.
Siting LiDepartment of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, China.
Yuxuan WangDepartment of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, China.
Xinru LiDepartment of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, China.
Juanjuan LiuDepartment of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, China.
Qing YangDepartment of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, China.
Xiao LiDepartment of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, China.ORCID https://orcid.org/0000-0003-4447-194X
Bei LinDepartment of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, China.ORCID https://orcid.org/0000-0001-5347-4881
China Medical University · CNLMU Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The occurrence and development of ovarian cancer (OV) are significantly influenced by increased levels of oxidative stress (OS) byproducts and the lack of an antioxidant stress repair system. Hence, it is necessary to explore the markers related to OS in OV, which can aid in predicting the prognosis and immunotherapeutic response in patients with OV. Methods: The single-cell RNA-sequencing (scRNA-seq) dataset GSE146026 was retrieved from the Gene Expression Omnibus (GEO) database, and Bulk RNA-seq data were obtained from TCGA and GTEx databases. The Seurat R package and SingleR package were used to analyze scRNA-seq and to identify OS response-related clusters based on ROS markers. The "limma" R package was used to identify the differentially expressed genes (DEGs) between normal and ovarian samples. The risk model was constructed using the least absolute shrinkage and selection operator (LASSO) regression analysis. The immune cell infiltration, genomic mutation, and drug sensitivity of the model were analyzed using the CIBERSORT algorithm, the "maftools," and the "pRRophetic" R packages, respectively. Results: Based on scRNA-seq data, we identified 12 clusters; OS response-related genes had the strongest specificity for cluster 12. A total of 151 genes were identified from 2928 DEGs to be significantly correlated with OS response. Finally, nine prognostic genes were used to construct the risk score (RS) model. The risk score model was an independent prognostic factor for OV. The gene mutation frequency and tumor immune microenvironment in the high- and low-risk score groups were significantly different. The value of the risk score model in predicting immunotherapeutic outcomes was confirmed. Conclusions: OS response-related RS model could predict the prognosis and immune responses in patients with OV and provide new strategies for cancer treatment.

Indexed as

Ovarian NeoplasmsBase SequenceBiomarkersBiomarkers, TumorFemaleHumansOxidative StressRNA-SeqTumor MicroenvironmentBiomarkersBiomarkers, Tumor

Identifiers

PMID36743693
PMCPMC9897923
OpenAlexW4318257722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.